|
Device | ORSIRO Sirolimus Eluting Coronary Stent System |
Generic Name | Coronary drug-eluting stent |
Applicant | Biotronik, Inc 6024 Jean Road Lake Oswego, OR 97035 |
PMA Number | P170030 |
Date Received | 09/27/2017 |
Decision Date | 02/22/2019 |
Product Code |
NIQ |
Docket Number | 19M-0885 |
Notice Date | 02/25/2019 |
Advisory Committee |
Cardiovascular |
Clinical Trials | NCT02389946
|
Expedited Review Granted? | No |
Combination Product | Yes |
Approval Order Statement Approval of the Orsiro Sirolimus Eluting Coronary Stent System. This device is indicated for improving coronary luminal diameter in patients, including those with diabetes mellitus, with symptomatic heart disease, stable angina, unstable angina, non-ST elevation myocardial infarction or documented silent ischemia due to atherosclerotic lesions in the native coronary arteries with a reference vessel diameter of 2.25 mm to 4.0 mm and a lesion length of < 36 mm. |
Approval Order | Approval Order |
Summary | Summary of Safety and Effectiveness |
Labeling | Labeling Labeling Part 2 |
Post-Approval Study | Show Report Schedule and Study Progress |
Supplements: |
S001 S002 S003 S015 S023 S019 S020 S014 S028 S029 S006 S004 S005 S010 S011 S012 S013 S007 S008 S021 S017 S027 S024 S025 S026 S016 S022 S018 S036 S037 S030 S031 S032 S033 S034
|